FRE — Firebrick Pharma Balance Sheet
0.000.00%
- AU$13.03m
- AU$12.04m
- AU$0.29m
Annual balance sheet for Firebrick Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.15 | 7.14 | 2.35 | 0.825 | 0.983 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.503 | 1.08 | 0.137 | 0.951 | 0.258 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.67 | 8.33 | 2.59 | 2.09 | 1.48 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.016 | 0.042 | 0.034 | 0.027 | 0.095 |
| Other Long Term Assets | |||||
| Total Assets | 1.76 | 8.73 | 2.98 | 2.41 | 1.83 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.215 | 0.45 | 0.506 | 0.291 | 0.271 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.215 | 0.45 | 0.506 | 0.291 | 0.271 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.55 | 8.28 | 2.48 | 2.12 | 1.56 |
| Total Liabilities & Shareholders' Equity | 1.76 | 8.73 | 2.98 | 2.41 | 1.83 |
| Total Common Shares Outstanding |